ASCO Education: By the Book delivers in-depth discussions with the editors and authors behind the ASCO Educational Book. Hear about key topics from ASCO meetings education sessions, perspectives on the state of the science, and deep dives into the complex approaches shaping modern oncology practice.
ASCO Education
Claim This Podcastby American Society of Clinical Oncology (ASCO)
5.0(3 reviews)
198 episodes
Updated Inactive
Accepts GuestsHas SponsorsLocation 🇺🇸
53
Podcast Authority
BetaFairBased on show quality, social media presence, reviews, charts, and more
Quality87
Social0
YouTube0
Engagement51
Podcast Overview
ASCO Education: By the Book delivers in-depth discussions with the editors and authors behind the ASCO Educational Book. Hear about key topics from ASCO meetings education sessions, perspectives on the state of the science, and deep dives into the complex approaches shaping modern oncology practice.
Language
🇺🇲
Publishing Since
4/19/2017
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
53
Podcast Authority
BetaFairBased on show quality, social media presence, reviews, charts, and more
Quality87
Social0
YouTube0
Engagement51
7
Excellent Areas
2
Good Performance
10
Growth Opportunities
excellent
Episode Length
28 minutes
Performing excellently!
good
Show Notes Quality
3.0/5
Recommendations available
Unlock the full report to see detailed tips
needs improvement
Publishing Consistency
Every 16 days
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
2 verified contact emails on file for ASCO Education
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 8, 2026
Expanding Precision Oncology With Targeted Immunotherapy
Dr. Pedro Barata and Dr. Bridget Keenan explore how bioengineering targets immune-cold tumors and brings bispecific therapies to outpatient clinics, offering insights into predictive biomarkers and resistance.
May 11, 2026
Beyond Chronological Age: Assessing Frailty in Older Adults With GU Cancer
<p><span data-olk-copy-source="MessageBody">Dr. Hope Rugo and Dr. Peter Lee discuss </span><a id= "OWAf62a88d0-0460-ef82-7b8c-d754da742786" title= "Original URL: https://ascopubs.org/doi/full/10.1200/EDBK-26-516010. Click or tap if you trust this link." href= "https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fascopubs.org%2Fdoi%2Ffull%2F10.1200%2FEDBK-26-516010&data=05%7C02%7CLeslie.Pedder%40asco.org%7C75b7e066829c4137ddc508deaf89d8b6%7C7547dabb460c4dd482355b01b417ca8a%7C1%7C0%7C639141203792702850%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=n2tz9qlDpF3p4e9Xp11VnGFbkb1xa0WHw06JFbweVQ8%3D&reserved=0" data-auth="NotApplicable" data-linkindex="0"><u>frailty, geriatric assessments, and personalized care for older adults with genitourinary cancer</u></a>. They highlight screening guidelines, treatment considerations, multidisciplinary interventions, and the emergence of AI and digital health tools in geriatric oncology.</p> <p><a href= "https://ascopubs.org/do/beyond-chronological-age-assessing-frailty-older-adults-gu-cancer" target="_blank" rel="noopener"><strong>LINK TO FULL TRANSCRIPT</strong></a></p> <p> </p> <p> </p>
April 13, 2026
Liver-Directed Therapies for Colorectal Cancer: Where Are We Now?
<p>Drs. Pedro Barata, Yi Song, Meenakshi Jeeva, and Lauren Park discuss liver-directed therapies in colorectal cancer, ongoing developments in locoregional therapies for unresectable colorectal liver metastasis, and exciting research on expanding the role of thermal ablation in liver-dominant metastatic CRC.</p> <p><a href= "ascopubs.org/do/liver-directed-therapies-colorectal-cancer-we-now" target="_blank" rel="noopener"><strong>LINK TO FULL TRANSCRIPT</strong></a></p>
198 total episodes available with 2 transcripts
Recent guests on ASCO Education
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Pedro Barata
Guest
Bridget Keenan
Guest
Dr Cheryl Czerlanis
Guest
Dr Chloe Atreya
Guest
Similar Podcasts
Discover related shows you might enjoy
ASCO Daily News
American Society of Clinical Oncology (ASCO)
ASCO Guidelines
American Society of Clinical Oncology (ASCO)
Journal of Clinical Oncology (JCO) Podcast
American Society of Clinical Oncology (ASCO)
Two Onc Docs
Sam and Karine
NEJM This Week
NEJM Group
Oncology Brothers
Oncology Brothers
JCO Oncology Practice Podcast
American Society of Clinical Oncology (ASCO)
Oncology Today with Dr Neil Love
Dr. Neil Love
JCO Precision Oncology Conversations
American Society of Clinical Oncology (ASCO)
OncLive® On Air
OncLive® On Air
Gastrointestinal Cancer Update
Dr. Neil Love
Cancer Stories: The Art of Oncology
American Society of Clinical Oncology (ASCO)
The Oncology Podcast
The Oncology Network
Research To Practice | Oncology Videos
Dr Neil Love
Lung Cancer Update
Dr. Neil Love
Deep-dive analytics for ASCO Education
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is ASCO Education?
- How often does this podcast release new episodes?
This podcast updates inactive.
- Where can I listen to this podcast?
This podcast is available on 2 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.